# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-020088
Filing Date
2023-05-10
Accepted
2023-05-10 07:31:07
Documents
61
Period of Report
2023-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | tcrt-20230331.htm iXBRL | 10-Q | 1777504
2 | EX-10.1 | tcrt-ex10_1.htm | EX-10 | 405738
3 | EX-10.2 | tcrt-ex10_2.htm | EX-10 | 27331
4 | EX-10.3 | tcrt-ex10_3.htm | EX-10 | 39216
5 | EX-10.4 | tcrt-ex10_4.htm | EX-10 | 189843
6 | EX-31.1 | tcrt-ex31_1.htm | EX-31 | 16560
7 | EX-32.1 | tcrt-ex32_1.htm | EX-32 | 8754
8 | GRAPHIC | img42087188_0.jpg | GRAPHIC | 5744
| Complete submission text file | 0000950170-23-020088.txt |  | 7043217

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | tcrt-20230331.xsd | EX-101.SCH | 58573
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | tcrt-20230331_pre.xml | EX-101.PRE | 353093
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | tcrt-20230331_def.xml | EX-101.DEF | 268568
12 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | tcrt-20230331_lab.xml | EX-101.LAB | 465223
13 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | tcrt-20230331_cal.xml | EX-101.CAL | 29803
55 | EXTRACTED XBRL INSTANCE DOCUMENT | tcrt-20230331_htm.xml | XML | 778064

Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33038 | Film No.: 23904348
SIC: 2834 Pharmaceutical Preparations